Research Topic · Peer-Reviewed

High Throughput Screening

High-throughput screening (HTS) is an experimental approach that rapidly tests very large numbers of chemical compounds, biological samples, or genetic perturbations against a defined biological target or assay to identify active candidates. Central to early drug discovery, it uses miniaturised assays in microplate …

Curated from this journal's research 📚 5 peer-reviewed articles cited Cited 32× across the literature 🗓 Reviewed July 2026

Overview

High-throughput screening (HTS) is an experimental approach that rapidly tests very large numbers of chemical compounds, biological samples, or genetic perturbations against a defined biological target or assay to identify active candidates. Central to early drug discovery, it uses miniaturised assays in microplate formats, laboratory automation and robotics, sensitive detection systems, and data-analysis pipelines to evaluate thousands to millions of samples efficiently. Assays are designed as readouts of a biological response, such as enzyme activity, receptor binding, gene expression, or cellular signalling, and may be biochemical or cell-based; functional cellular assays, including calcium-transient and other phenotypic measurements in human induced pluripotent stem cell-derived cells, allow screening in physiologically relevant systems. Compounds that produce a desired effect are flagged as hits and progress through confirmation, dose-response characterisation, and counter-screening to remove artefacts and establish selectivity, yielding validated leads for medicinal-chemistry optimisation. HTS complements computational and structure-based methods, with in silico screening and rational design used to focus libraries and prioritise candidates for in vitro and in vivo testing. It is applied to small-molecule discovery, target validation, and the profiling of compound activity and toxicity. As a scalable engine for hit identification, high-throughput screening links library design, assay development, automation, and informatics within modern molecular biology and pharmaceutical research.

Research published in this journal

5 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2022

A Review on Drug Design by the Application of Computer

S. Patil NikitaCorresponding author
Department of Pharmaceutics P.S.G.V.P.M’s College of Pharmacy, Shahada.
Exact topic Advanced Pharmaceutical Science And Technology doi:10.14302/issn.2328-0182.japst-22-4363

How this research is being cited

The 5 articles above have been cited 32 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on High Throughput Screening, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in New Developments in Molecular Biology.

Journal editorial board
Chengyue Zhang · United States MARINA PISCOPO · Italy

This page summarises published research for orientation; it is not medical or professional advice.